FIELD: organic chemistry, steroids, pharmacy. SUBSTANCE: invention relates to a new derivative of 11-(phenyl-substituted)-estra-4,9-diene of the formula (I) where A means a residue of 5- or 6-membered ring containing two heteroatoms which are not bound each with other and taken independently from O and S; indicated ring can be substituted with one or more halogen atoms; or residue of 5- or 6-membered ring where double bond C=C is absent has one heteroatom taken from O and S and heteroatom is bound with phenyl group at position noted by asterisk and ring can be substituted with one or more halogen atoms; R1 means hydrogen atom; R2 means hydrogen atom, (C1-8)-alkyl, halogen atom or CF3; X means O or NOH; and dotted line means a possible bond. Compounds show antiglucocorticoid activity and can be used for treatment and prophylaxis of glucocortcoid-dependent diseases. Invention describes also a method of synthesis of the above indicated compounds and a pharmaceutical composition based on compounds of the formula (I). EFFECT: improved method of synthesis, valuable pharmacological properties. 9 cl, 1 tbl, 13 ex
Title | Year | Author | Number |
---|---|---|---|
DERIVATIVES OF 11,21-BISPHENYL-19-NORPREGNANE, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION AND METHOD OF ITS PREPARING | 1995 |
|
RU2152952C2 |
DERIVATIVES OF 16-HYDROXY-11-(SUBSTITUTED PHENYL)-ESTRA-4,9-DIENE, COMPOUND, PHARMACEUTICAL COMPOSITION | 1998 |
|
RU2187510C2 |
STEROID WITH 17-SPIROMETHYLENELACTONE GROUP AND METHOD OF ITS SYNTHESIS | 1995 |
|
RU2168516C2 |
3-METHYLENE-STEROID DERIVATIVES, PHARMACEUTICAL COMPOSITION, METHOD FOR TREATMENT | 2000 |
|
RU2248358C2 |
PROGESTERONE RECEPTOR MODULATORS | 2005 |
|
RU2381232C2 |
COMPOUNDS, SET, ANDROGENIC COMPOSITION | 2000 |
|
RU2242479C2 |
STEROID COMPOUND, METHODS OF ITS SYNTHESIS, PHARMACEUTICAL COMPOSITION | 1998 |
|
RU2182153C2 |
HORMONAL OR ANTI-HORMONAL STEROID COMPOUNDS, METHODS FOR THERAPEUTIC EFFECT, METHOD FOR PREPARING COMPOUNDS | 1999 |
|
RU2238943C2 |
PROGESTERONE ANTAGONISTS | 2012 |
|
RU2608521C2 |
DERIVATIVES OF 11β-BENZALDOXIME-ESTRA-4,9-DIENE, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION | 1994 |
|
RU2137777C1 |
Authors
Dates
1999-08-27—Published
1996-08-16—Filed